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Abstract: A 70% ethanol extract from azuki beans (Vigna angularis) was extracted further 
with CH2Cl2, EtOAc and n-BuOH to afford four fractions: CH2Cl2-soluble, EtOAc-soluble, 
n-BuOH-soluble and residual extract fractions. The EtOAc-soluble fractions showed the 
highest  α-glucosidase  inhibitory  activity.  Two  pure  flavonoid  compounds,  vitexin  and 
isovitexin, were isolated (using the enzyme assay-guide  fractionation  method) from the 
EtOAc-soluble  fractions.  We  further  evaluated  the  interaction  between  the  flavonoid 
compounds  and  α-glucosidase  by  fluorescence  spectroscopy.  Vitexin  and  isovitexin 
showed  high  inhibitory  activities,  with  IC50  values  of  0.4  mg·mL
−1  and  4.8  mg·mL
−1, 
respectively.  This  is  the  first  study  of  the  active  compositions  of  azuki  beans  against  
α-glucosidase. 
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1. Introduction 
Interest in glucosidase  inhibitors is growing  because of  its  implications  for the  management of 
diabetes  mellitus  (DM).  DM  is  a  serious  metabolic  disorder that  affects  approximately  4%  of  the 
population worldwide and is expected to increase to affect 5.4% by 2025 [1]. Acting as a key enzyme 
for carbohydrate digestion, intestinal α-glucosidase is one of the glucosidases located at the epithelium 
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of the small intestine. α-glucosidase has been recognized as a therapeutic target for the modulation of 
postprandial hyperglycemia, which is the earliest metabolic abnormality to occur in type 2 diabetes 
mellitus [2,3]. The inhibition on intestinal α-glucosidases would delay the digestion and absorption of 
carbohydrates and consequently suppress the postprandial hyperglycemia [4].  
Azuki beans have been a subject of extensive investigation due to their biological activities. In the 
past, they have been recommended as suitable foods for diabetic patients due to their high fiber and 
protein  contents  [5].  Recently,  they  have  also  been  reported  to  contain  considerable  quantities  of 
bioactive phytochemicals including phenolic compounds [6], which may offer extra benefits for the 
amelioration of diabetes. Itoh et al. [7] reported that azuki beans possess inhibition activity against α-
glucosidase in streptozotocin (STZ)-induced diabetic rats. However, the studies on anti-diabetic effects 
were focused on the activity of the extract; the active components of the extract were not ascertained. 
The present study was therefore carried out to isolate and identify the active compositions of azuki 
beans by enzyme assay-guided fractionation.  
2. Results and Discussion  
2.1. Isolation of Active Compounds and Structural Determination 
Itoh et al. [7] investigated the antidiabetic effects of azuki beans on streptozotocin (STZ)-induced 
diabetic rats. We also observed that azuki beans showed the highest α-glucosidase inhibition ability 
among  sixteen  legumes  (data  not  shown).  However,  the  active  components  of  the  extract  were  
not ascertained. In this study, two pure compounds were separated from the EtOAc-soluble fraction by 
the method mentioned above; they were identified as vitexin and isovitexin (structures are shown in 
Figures 1 and 2), by comparison of their spectral data with those in the literature [8,9].  
Figure 1. Chemical structures of vitexin. 
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Vitexin (1): yellow powder. 
1H NMR (500 MHz, DMSO-d6) d: 13.15 (1H, s, OH-5), 8.01 (2H, d,  
J = 8.7 Hz, H-2', 6'), 6.86 (2H, d, J = 8.7 Hz, H-3', 5'), 6.76 (1H, s, H-3), 6.23 (1H, s, H-6), 4.69 (1H, 
d, J = 9.8 Hz, H-1' of glu), 3.85–3.22 (6H, m, glucosyl H). 
13C NMR (DMSO-d 6) d: 182.0 (C-4),  
164.8  (C-2),  162.7  (C-7)  161.3  (C-4'),  160.4  (C-5),156.09  (C-9),  128.5  (C-2',  6'),  121.2  (C-1'),  
115.8 (C-3', 5'), 104.7 (C-10), 104.1 (C-8),102.4 (C-3), 98.2 (C-6). Positive ESI-MS: m/z 433 [M + H]
+. Int. J. Mol. Sci. 2011, 12  6447 
 
Figure 2. Chemical structures of isovitexin. 
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Isovitexin (2): yellow powder. 
1H NMR (500 MHz, DMSO-d6) d: 13.55 (1H, s, OH-5), 7.93 (2H, d,  
J = 8.8 Hz, H-2', 6'), 6.93 (2H, d, J = 8.8 Hz, H-3', 5'), 6.78 (1H, s, H-3), 6.51 (1H, s, H-8), 4.58 (1H, 
d, J = 9.8 Hz, H-1 of glu), 4.03–3.11 (6H, m, glucosyl H). 
13C NMR (DMSO d6) d: 181.9 (C-4),  
163.5  (C-2),  163.3  (C-7),  161.6  (C-4'),  160.6  (C-5),  158.2  (C-9),  128.4  (C-2',  6'),  121.1  (C-1'),  
116.06 (C-3', 5'), 108.9 (C-6), 103.4 (C-10), 102.8 (C-3), 93.64 (C-8). Positive ESI-MS: m/z 433 [M + H]
+. 
2.2. Alpha-Glucosidase Inhibition Activities 
To determine the α-glycosidase inhibition ability in vitro, we calculated the IC50 values (Table 1). 
The EtOAc-soluble fraction had the highest α-glucosidase inhibitory activity of the four partition parts. 
Vitexin was the most active (IC50 of 0.4 mg·mL
−1), followed by isovitexin (IC50 of 4.8 mg·mL
−1).  
Table  1.  Alpha-glucosidase  inhibitory  activity  of  CH2Cl2-soluble,  EtOAc-soluble,  
n-BuOH-soluble, residual extract, vitexin and isovitexin. 
Extracts/compounds  IC50 
CH2Cl2-soluble  >500 
EtOAc-soluble  53.74 
n-BuOH-soluble,  173.69 
Residual extract  >500 
Vitexin  0.4 
Isovitexin  4.8 
Acarbose  0.45 
IC50 was expressed as mg·mL
−1. 
2.3. Fluorescence Spectra 
Fluorescence quenching can be divided into two types: dynamic quenching and static quenching. 
Dynamic  quenching  stems  from  the  collision  between  two  fluorescent  luminophors,  while  static 
quenching  arises  from  the  formation  of  a  new  nonfluorescent  complex  that  forms  between  the 
fluorescent luminophors and quencher [10]. Dynamic quenching follows the Stern–Volmer equation [11]: 
F0/F = 1 + Ksv[Q] = 1 + Kqτ0[Q]  (1)  
where F0 and F are the fluorescence intensities of the fore-and-aft interaction between α-glucosidase 
and flavonoid, [Q] is the concentration of quencher and flavonoid, and τ0 is the average life of the Int. J. Mol. Sci. 2011, 12  6448 
 
fluorescent  substance  without  the  quencher,  valued  at  approximately  10
−8  s.  Ksv  and  Kq  are  the 
dynamic quenching constant and rate constant in the process of double molecule quenching [12].  
The quenching fluorescence spectra of α-glucosidase by flavonoids were recorded at 25 and 37 °C 
(Figures 3 and 4). The values of Ksv and Kq were obtained with the Stern-Volmer equation from plots 
of  linear  equations  obtained  by  F0/F  vs.  [Q].  The  values  of  Ksv  decreased  with  the  increase  of 
temperature, and Kq was greater than 2.0 × 10
10 (Table 2). Therefore, the process of quenching is a 
static quenching by the formation of a complex.  
Table  2.  Constants  of  Ksv  and  Kq  of  the  interaction  between  α-glucosidase  and  
vitexin, isovitexin. 
 
T 
(°C) 
KSV/105 
(L·mol
−1) 
Kq/1013 
(L·mol
−1·S
−1) 
R
2 
Vitexin  25  1.38  1.38  0.9436 
  37  1.13  1.13  0.9627 
Isovitexin  25  1.06  1.06  0.9829 
  37  0.98  0.98  0.9807 
Static quenching follows the equations [13]: 
lg 
F0 − F
F  = lg KA + n lg [Q]f  (2)  
[flavonoid]f =[flavonoid] − n [α-glucosidase-flavonoid n]  (3)  
[α-glucosidase-flavonoidn] = 
F0 − F
F0 − F∞
 [α-glucosidase]  (4)  
Here, [Q]f is the concentration of free flavonoid, [flavonoid]f; and [α-glucosidase-flavonoid n] is the 
concentration of α-glucosidase bound with the flavonoid. 
The vitexin binding constant (KA) is higher than the isovitexin constant (Table 3). The number of 
binding sites (n) was close to one at 37 °C, which is the most suitable temperature for the flavonoid 
molecules to bind with α-glucosidase. 
Table  3.  Values  of  KA  and  n  of  the  interaction  between  α-glucosidase  and  
vitexin, isovitexin. 
 
T 
(°C) 
KA/105 
(L·mol
−1) 
n  R
2 
Vitexin  25  1.23  1.21  0.9865 
  37  1.37  1.24  0.9940 
Isovitexin  25  1.19  1.09  0.9671 
  37  1.25  1.17  0.9513 Int. J. Mol. Sci. 2011, 12  6449 
 
Figure 3. The effect of vitexin on fluorescence spectrum of α-glucosidase after they were 
added to the enzyme solution. 
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Figure 4. The effect of isovitexin on fluorescence spectrum of α-glucosidase after they 
were added to the enzyme solution. 
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3. Materials and Methods 
3.1. Materials 
Azuki  beans  were  provided  by  the  Chinese  National  Genebank  (Beijing,  China).  Rat  intestinal 
acetone powder was purchased from Sigma-Aldrich (St. Louis, MO, USA). Acarbose was purchased 
from Bayer Health Care Pharmaceuticals, Inc. (USA). All chemicals used were of analytical grade and 
were obtained from Beijing Chemical Reagent (Beijing, China). Silica gel (200–300 mesh) for column 
chromatography  was  purchased  from  Qingdao  Marine  Chemical  Company  (Qingdao,  China). 
Sephadex LH-20 was purchased from GE Healthcare (Sweden, USA). 
3.2. Isolation and Identification of Active Compounds 
Dried Azuki beans (3.0 kg) were crushed and twice extracted with 70% ethanol (3 × 10 L) for 2 h at 
60 °C. The extracts were combined and concentrated under vacuum at 50 °C. Then, the concentrated 
extracts were partitioned with CH2Cl2, EtOAc and n-BuOH to offer four extracts: the CH2Cl2-soluble, 
EtOAc-soluble, n-BuOH-soluble and residual extract fractions. Each extract was evaporated to dryness 
under  reduced  pressure,  while  the  residual  extract  fraction  was  frozen  to  dryness.  Therefore,  five 
extracts were obtained in total. A small amount of each fraction was redissolved in 50% dimethyl 
sulfoxide  (DMSO),  and  these  mixture  solutions  were  subjected  to  α-glucosidase  inhibitory  
activity assays. Int. J. Mol. Sci. 2011, 12  6450 
 
The EtOAc-soluble fraction (25 g) was subjected to a silica gel chromatography column, using an 
EtOAc/MeOH/H2O system as the eluent, and the polarity of the eluent was increased by increasing the 
ratio of EtOAc during the process. The separation was monitored by TLC, and four fractions were 
obtained. Fraction 3 [EtOAc:MeOH:H2O = 8:1:0.2 (v:v:v)] showed strong inhibitory activities against 
α-glucosidase. A further separation was completed using a combination of Sephadex LH-20 column 
chromatography, with MeOH as the eluent, and reversed-phase TLC to monitor the isolation. 
3.3. Evaluation of α-Glucosidase Inhibitory Activity 
The  α-glucosidase  inhibitory  activity  was  determined  as  previously  described  with  slight 
modifications  [14,15].  The  inhibition  activity  of  α-glucosidase  (1  unit·mL
−1)  was  assayed  using  
50  μL  of  extracts  with  varying  concentrations  incubated  with  100  μL  of  0.1  M  phosphate  buffer  
(pH 7.0) in 96-well plates at 37 °C for 10 min. After preincubation, 50 μL of 5 mM p-nitrophenyl-α-D-
glucopyranoside solution in 0.1 M phosphate buffer (pH 7.0) was added to each well at varying time 
intervals. The reaction mixtures were incubated at 37 °C for 5 min. The absorbance readings were 
recorded at 490 nm on a microplate reader before and after incubation (BioRad, IMAX, Hercules, 
USA). The results were expressed as a percent of α-glucosidase inhibition and calculated according to 
the following equation:  
% inhibition = Abs
control − Abs
extract × 100/Abs
control  (5)  
The IC50 value was defined as the concentration of bean extracts (acarbose) required to inhibit 50% 
of the enzyme activity. 
3.4. Measurement of Fluorescence Spectra  
The  fluorescence  spectra  were  determined  using  the  method  reported  by  Li  et  al.  [12].  The  
α-glucosidase  was  prepared  by  dissolving  solid  α-glucosidase  into  phosphate  buffer  
(0.1  mol·L
−1,  pH  6.8,  with  0.1  mol·L
−1  NaCl),  and  vitexin  (or  isovitexin)  was  dissolved  in  60% 
ethanol. For the FS measurement, a solution of 1.0 mL of α-glucosidase was added to a fluorescence 
cuvette at a given temperature and titrated with flavonoid for 5 min. Fluorescence spectra of the α-
glucosidase and α-glucosidase-flavonoid mixture were recorded in the range from 315 to 500 nm. The 
slits for both excitation and emission were set at 10 nm with an excitation wavelength of 295 nm and 
an optical path of 10 mm (Hitachi F-2500 fluorescence spectrophotometer, Japan). 
4. Conclusion 
In conclusion, two major active components, vitexin and isovitexin, were isolated from the azuki 
bean. There is a static quenching interaction between flavonoid compounds and α-glucosidase, and the 
most suitable temperature is 37 °C. 
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